Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of -4.21 is 113% below its 5-year average of -1.97, near the low end of its 5-year range (-13.19–882.73).
As of the fiscal period ended Tuesday, June 30, 2026. 12.61% above its 12-month average of -4.82.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): -4.21.
DEBT TO EQUITY RATIO
-4.21
DEBT TO EQUITY RATIO AVG TTM
-4.82
DEBT TO EQUITY RATIO AVG 3Y
-1.79
DEBT TO EQUITY RATIO AVG 5Y
-1.97
DEBT TO EQUITY RATIO AVG 10Y
-0.55
DEBT TO EQUITY RATIO AVG 15Y
-0.05
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+12.61%
CURRENT VS 3Y AVG
-135.05%
CURRENT VS 5Y AVG
-113.49%
CURRENT VS 10Y AVG
-662.85%
CURRENT VS 15Y AVG
-8939.21%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11
median of 774 covered companies
CURRENT VS SECTOR MEDIAN
-3928.87%
vs the sector median at left
PTC Therapeutics, Inc.
Market Cap
$5.32B
Debt to Equity Ratio
-4.21
TTM Avg
-4.82
3Y Avg
-1.79
5Y Avg
-1.97
Market Cap
$5.21B
Debt to Equity Ratio
0.45
TTM Avg
0.16
3Y Avg
0.15
5Y Avg
0.12
Market Cap
$5.21B
Debt to Equity Ratio
25.16
TTM Avg
4.83
3Y Avg
5.30
5Y Avg
3.87
Market Cap
$5.20B
Debt to Equity Ratio
3.41
TTM Avg
4.78
3Y Avg
5.15
5Y Avg
4.66
Market Cap
$5.19B
Debt to Equity Ratio
0.46
TTM Avg
0.24
3Y Avg
0.16
5Y Avg
0.11
Market Cap
$5.52B
Debt to Equity Ratio
0.02
TTM Avg
0.02
3Y Avg
0.01
5Y Avg
0.01
Market Cap
$5.09B
Debt to Equity Ratio
0.80
TTM Avg
0.31
3Y Avg
0.29
5Y Avg
0.31
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PTC Therapeutics, Inc. (PTCT) | $5.32B | -4.21 | -4.82 | -1.79 | -1.97 |
| CRISPR Therapeutics AG (CRSP)vs › | $5.21B | 0.45 | 0.16 | 0.15 | 0.12 |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.21B | 25.16 | 4.83 | 5.30 | 3.87 |
| Sotera Health Company (SHC)vs › | $5.20B | 3.41 | 4.78 | 5.15 | 4.66 |
| Doximity, Inc. (DOCS)vs › | $5.20B | 0.01 | 0.01 | 0.02 | 0.01 |
| Cogent Biosciences, Inc. (COGT)vs › | $5.19B | 0.46 | 0.24 | 0.16 | 0.11 |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | 0.02 | 0.02 | 0.01 | 0.01 |
| RadNet, Inc. (RDNT)vs › | $5.53B | 1.99 | 1.81 | 2.63 | 3.97 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.09B | 0.80 | 0.31 | 0.29 | 0.31 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 0.49 | 0.57 | 0.53 | 0.48 |
Debt/Equity
-4.21
Current Ratio
3.39
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | -4.21 |
| 2026-03-31 | -2.19 |
| 2025-12-31 | -13.19 |
| 2025-09-30 | -2.63 |
| 2025-06-30 | -1.88 |
| 2025-03-31 | -2.10 |
| 2024-12-31 | -2.25 |
| 2024-09-30 | -0.38 |
| 2024-06-30 | -0.40 |
| 2024-03-31 | -0.47 |
| 2023-12-31 | -2.72 |
| 2023-09-30 | -1.05 |
| 2023-06-30 | -1.21 |
| 2023-03-31 | -1.53 |
| 2022-12-31 | -4.21 |
| 2022-09-30 | -1.83 |
| 2022-06-30 | -3.29 |
| 2022-03-31 | -5.87 |
| 2021-12-31 | 882.73 |
| 2021-09-30 | 5.10 |
| 2021-06-30 | 2.73 |
| 2021-03-31 | 1.84 |
| 2020-12-31 | 0.87 |
| 2020-09-30 | 0.81 |
| 2020-06-30 | 0.60 |
| 2020-03-31 | 0.59 |
| 2019-12-31 | 0.55 |
| 2019-09-30 | 0.47 |
| 2019-06-30 | 0.32 |
| 2019-03-31 | 0.30 |
| 2018-12-31 | 0.44 |
| 2018-09-30 | 0.39 |
| 2018-06-30 | 0.56 |
| 2018-03-31 | 0.98 |
| 2017-12-31 | 0.93 |
| 2017-09-30 | 0.98 |
| 2017-06-30 | 0.83 |
| 2017-03-31 | 0.99 |
| 2016-12-31 | 0.82 |
| 2016-09-30 | 0.69 |
| 2016-06-30 | 0.57 |
| 2016-03-31 | 0.48 |
| 2015-12-31 | 0.32 |
| 2015-09-30 | 0.35 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 0.00 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
| 2013-12-31 | 0.00 |
| 2013-09-30 | 0.00 |
| 2013-06-30 | 0.02 |
| 2013-03-31 | 0.11 |
| 2012-12-31 | -0.25 |
| 2012-09-30 | 0.00 |
| 2012-06-30 | 0.00 |
| 2012-03-31 | 0.00 |
